Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral melatonin in neonatal procedural pain
PACTR202407517097387Phase 3Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in procedural pain and neonatal condition (2 arms), sponsored by Kafrelsheikh University. Primary endpoints: Neonatal Infant Pain Scale score and Neonatal Pain, Agitation and Sedation Scale score. Started May 2024; status: recruiting.
02
Drugs
melatonin
03
Conditions
procedural painneonatal condition
Beyond the preview
Go deeper on PACTR202407517097387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202407517097387.